期刊： ANTIVIRAL THERAPY, 2019; 24 (2)
Background: Peginterferon alfa-2a (PEG-IFN) treatment stopping rules in chronic hepatitis B (CHB) are clinically desirable. Previous studies exploring......
期刊： ANTIVIRAL THERAPY, 2019; 24 (2)
Background: Tenofovir disoproxil fumarate (TDF) administration in the third trimester for pregnant women with high HBV DNA load has been accepted as a......
期刊： ANTIVIRAL THERAPY, 2019; 24 (2)
Background: This study was aimed at evaluating the clinical significance of serum HBV RNA, hepatitis B core-related antigen (HBcrAg) and hepatitis B c......
期刊： ANTIVIRAL THERAPY, 2019; 24 (2)
Background: Recent studies suggest that serum lipids are associated with pegylated interferon-alpha (PEG-IFN-alpha) treatment response in chronic hepa......
期刊： ANTIVIRAL THERAPY, 2019; 24 (1)
Background: In previous research, we have demonstrated that sodium tanshinone IIA sulfonate (STS) has anti-porcine reproductive and respiratory syndro......
期刊： ANTIVIRAL THERAPY, 2018; 23 (1)
Background: High genetic variability at the reverse transcriptase (RT) region of HBV could confer resistance to nucleoside/nucleotide analogues (NUCs)......
期刊： ANTIVIRAL THERAPY, 2018; 23 (7)
Background: Influenza A viruses (IAV) can cause pandemics and are big threats to human health. Inflammation is the main pathological process in the lu......
期刊： ANTIVIRAL THERAPY, 2018; 23 (7)
Background: Interferon (IFN)-alpha is widely used for the treatment of chronic hepatitis B (CHB) infection due to the high rate of hepatitis B surface......
期刊： ANTIVIRAL THERAPY, 2018; 23 (7)
Background: The correlation between hepatitis B surface antigen (HBsAg) seroconversion and the characteristics of HBV quasispecies (QS) before and dur......
期刊： ANTIVIRAL THERAPY, 2018; 23 (5)
Background: Porcine reproductive and respiratory syndrome virus (PRRSV) is an important pathogen that causes economically huge losses to the pig indus......
期刊： ANTIVIRAL THERAPY, 2018; 23 (3)
Background: In China, the clinical management of chronic hepatitis B (CHB) is complicated by the use of various-nucleoside/nucleotide analogue (NUC) r......
期刊： ANTIVIRAL THERAPY, 2017; 22 (1)
Background: Nucleoside/nucleotide analogues are widely used to treat chronic HBV infection, but drug resistance is common. The role of HBV surface gen......
期刊： ANTIVIRAL THERAPY, 2017; 22 (2)
Background: To describe direct medical costs of influenza in hospitalized elderly, with and without intensive care unit (ICU) admission, during the 20......
